Cargando…
Cerebral Cavernous Malformation 1 Determines YAP/TAZ Signaling-Dependent Metastatic Hallmarks of Prostate Cancer Cells
SIMPLE SUMMARY: Our analysis of cerebral cavernous malformation 1 (CCM1) expression and function reveals a candidate predictive biomarker for prostate cancer metastasis and provides evidence that CCM1 abnormality can be pathogenic in prostate cancer. In particular, the CCM1 regulation of metastasis...
Autores principales: | Park, Sangryong, Lee, Ho-Young, Kim, Jayoung, Park, Hansol, Ju, Young Seok, Kim, Eung-Gook, Kim, Jaehong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7961486/ https://www.ncbi.nlm.nih.gov/pubmed/33807895 http://dx.doi.org/10.3390/cancers13051125 |
Ejemplares similares
-
Introduction to cerebral cavernous malformation: a brief review
por: Kim, Jaehong
Publicado: (2016) -
Hippo-YAP/TAZ signaling in angiogenesis
por: Park, Jeong Ae, et al.
Publicado: (2018) -
Unusual Presentation of Cerebral Cavernous Malformation
por: Kim, Won-Hyung, et al.
Publicado: (2015) -
YAP/TAZ initiate and maintain Schwann cell myelination
por: Grove, Matthew, et al.
Publicado: (2017) -
DNA binding partners of YAP/TAZ
por: Kim, Min-Kyu, et al.
Publicado: (2018)